Amy G. Eastman

· Promoted from Sr. Consultant II to Practice Specialist

· Brought on to facilitate build out of pharma practice

· Determined project needs with new pharma clients

· Helped acquire two rare disease clients worth $500,000

· Revamped life sciences collateral with VP highlighting project specialties, company differentiation and life science skills

· Presented to internal stakeholders including C-Suite helping to secure additional projects

· Managed conference teams to assure client satisfaction, including appropriate coverage, actionable intelligence, onsite communications and final deliverables and presentations

· Promoted four times in six years from Analyst to Project Manager

· Led multiple concurrent projects in all aspects including research direction, data analysis, client and team management, deliverable preparation, and reporting to Brand Managers, CI professionals and C-Suite clients.

· Controlled project scope and budget, SOW and KIQ development, and capabilities presentations

· Led teams of multiple analysts with average project timeframes of 6-10 weeks and conducted year-round competitor monitoring

· Supplied industry trend analysis for the second largest pet food manufacturer in the world to support product redesigns and defend and grow market share

· Fortune 500 Client created a new patient savings program after in-depth analysis of competitor offerings

· Facilitated project bids worth up to $400,000 by showing detailed knowledge of key client challenges via therapeutic disease state proficiency in oncology, depression, rheumatology, and others

· Delivered strategic recommendations about product labeling, study design, and market access to global client with $4B in the U.S which resulted in a decision to pursue a novel mechanism-of-action status designation with the FDA

· Managed outside consultants in Japan, Europe and Latin America through all project phases including contracting, planning, research, and deliverables allowing for consistent reporting and actionable information in countries beyond the United States

· Enabled clients to improve brand planning strategy by providing visibility into competitor sales force movements, pipeline asset strategies, lifecycle management, brand identities, launch tactics and more utilizing conference intelligence to support primary research and analyses

• Promoted from field sales to hospital sales during a 30% reduction in sales headcount due to a company merger
• Promoted from primary care sales representative to professional rep, and Sr. Professional rep in two years
• Sold a wide range of pharmaceutical products to 300+ specialists, pharmacists and hospitalists including infectious diseases, pain management and gastroenterology in a large 3-state territory
• Solidified 5 of 6 hospital pharmacy contracts worth over $5 million, placing #1 product target on in-house formulary as the preferred product within my first 6 months
• Salvaged a $100,000 Dermabond contract at a 566-bed teaching institution
• Ranked 1 of 125 for Levaquin share change contest during the Summer of 2006
• Consistently ranked 1st or 2nd in the region as part of a team selling environment contributing to enhanced company sales 2003-2005
• Top 20% of national sales rankings every quarter from 2004 forward
• Exceeded all product goals in 2005
• Consistently ranked in top 3 of 40 sales teams in the region from 2003-2005
• Ranked 17 of 500 in nation for performance quotient resulting in market share change of 1.56% and 3.85% from Jan-June 2003; ended at 60/500 for overall performance quotient due to change in managed care environment in VT
• Chosen as 1 of 15 from a sales team of 120 to discuss company strategy, and was appointed customer relations manager and Siebel systems coordinator
• Delivered presentation at bi-national meeting designed to share the retooled selling methodology utilized for Dermabond

• Fast starter in an abandoned territory resulting in accelerated market share growth for flagship product and maintained a history of exceeding sales goals throughout portfolio and tenure
• Secured leading physician speakers for programs to help grow market share
• Achieved 70% market share growth year over year with primary product during first year in the field, effectively enhancing brand recognition in my territory and resulting in a promotion
• Achieved Top 25 award for sales contest increasing total number of Skelaxin and Sonata prescriptions by 12% (#2) and 8% (#3 )respectively
• Developed territory cycle and targeting plan resulting in improved routing efficiency focused on high value Physicians